Bath & Body Works, INC

Bath & Body Works announced a partial redemption of $250 million in 7.500% Senior Notes due 2029, with a redemption date set for August 19, 2026.

Bath & Body Works held its Annual Meeting of Stockholders on June 11, 2026, with key votes on director elections, auditor ratification, and executive compensation.

Bath & Body Works reported first quarter 2026 results exceeding guidance, with net sales down 3% and adjusted EPS of $0.32, while announcing CFO Eva Boratto's departure and appointing an interim CFO.

Bath & Body Works reported fourth quarter results above guidance but provided a cautious outlook for full-year 2026 with anticipated sales declines and lower adjusted earnings per share.

Bath & Body Works, Inc. announced the redemption of its 6.694% Senior Notes due 2027, effective April 10, 2026.

Bath & Body Works, Inc. announced that Michael Wu has ceased serving as Chief Legal Officer and Corporate Secretary, effective February 24, 2026.

Bath & Body Works reported a 3.2% decrease in net sales for Q1 2026 compared to the prior year, but saw a significant increase in operating income driven by a one-time litigation settlement gain.

Bath & Body Works reports a significant drop in third-quarter net income and operating income, with sales declining and management acknowledging underperformance and a challenging consumer environment.

Bath & Body Works reported a 1.5% increase in second-quarter net sales to $1.549 billion, but net income fell significantly to $64 million from $152 million year-over-year, impacted by leadership transition costs.

Bath & Body Works, Inc. (BBWI) announced robust first-quarter 2025 financial results, exceeding prior year performance in net sales, gross profit, and operating income, alongside a significant leadership transition with the appointment of Daniel Heaf as its new Chief Executive Officer.

Bath & Body Works' third-quarter results show a slight increase in net sales but a decrease in operating income, as the company invests in marketing and navigates a competitive market.

Bath & Body Works' second quarter results show a slight decrease in net sales but an increase in gross profit, driven by cost optimization initiatives and strategic investments.

Bath & Body Works reports a slight dip in 2025 net sales and operating income, initiating a multi-year 'Consumer First Formula' transformation plan for sustainable growth.

Bath & Body Works reports a slight dip in net sales for fiscal 2024, focusing on strategic priorities like top-line growth and cost management amidst economic pressures.

Bath & Body Works faced macroeconomic pressures in 2023, resulting in a slight decrease in net sales, but is focused on strategic initiatives to drive future growth and profitability.

Steven E. Voskuil, a Director at Bath & Body Works, Inc., received an annual award of restricted stock units.

Bath & Body Works reports an annual award of restricted stock units to independent director Rajlin Juan.

Danielle M. Lee, a Director at Bath & Body Works, Inc., received an annual award of restricted stock units.

James Kevin Symancyk, a Director at Bath & Body Works, Inc., received an annual award of restricted stock units.

Bath & Body Works, Inc. reports an annual stock award to independent director Francis Hondal.

Sarah E. Nash, a Director at Bath & Body Works, Inc., acquired 13,284 shares of common stock through an annual award of restricted stock units.

Bath & Body Works outlines its 'Consumer First Formula' strategy and key governance matters in its 2026 Proxy Statement, seeking shareholder support for director nominees and executive compensation.

Bath & Body Works announces the appointment of Daniel Heaf as CEO, replacing Gina R. Boswell, who has resigned from the position and will no longer stand for election as a director.

Bath & Body Works will hold its annual shareholder meeting virtually on June 5, 2025, to vote on director elections, auditor ratification, and executive compensation.

Bath & Body Works focuses on strategic priorities, cost optimization, and shareholder returns, signaling confidence in long-term growth.

Bath & Body Works will hold its annual shareholder meeting on June 27, 2024, to elect directors, ratify the appointment of the accounting firm, and vote on executive compensation.

Bath & Body Works seeks shareholder votes on director nominees, auditor ratification, and executive compensation in its upcoming annual meeting.

Vanguard Capital Management has reported beneficial ownership of 10,720,033 shares, representing 5.32% of the outstanding common stock of Bath & Body Works Inc.

Vanguard Portfolio Management has reported a beneficial ownership of 7.53% in Bath & Body Works Inc. common stock as of March 31, 2026.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 10.4% of Bath & Body Works Inc. common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Bath & Body Works Inc. following an internal realignment.

AQR Capital Management, LLC and its parent holding company have reported a beneficial ownership of 5.59% in Bath & Body Works, Inc. common stock.

FMR LLC and Abigail P. Johnson have reported an 8.3% beneficial ownership stake in Bath & Body Works Inc., holding over 17 million shares of common stock.